AI Article Synopsis
- The study examines TCAR (transcarotid artery revascularization stenting) as a treatment for patients with both carotid and cardiac disease, finding its effectiveness comparable to carotid endarterectomy (CEA).
- A review of 37 patients showed no major complications like heart or neurological issues after TCAR, although 8% did have a minor complication (neck hematoma).
- The results suggest that using TCAR before cardiac procedures is a safe and effective approach for patients with these dual conditions.
Article Abstract
Introduction: The optimal treatment strategy for patients with concomitant carotid and cardiac disease remains controversial. Transcarotid artery revascularization stenting with reversed flow protection (TCAR) has achieved results equivalent to carotid endarterectomy (CEA) in high risk patients.
Methods: A retrospective review of all patients at a single center who received staged TCAR prior to cardiac intervention was performed.
Results: 37 patients underwent 42 TCAR procedures prior to cardiac intervention (25 requiring open cardiac surgery and 12 requiring percutaneous intervention). There were no myocardial or neurological complications following TCAR prior to cardiac intervention. Three patients (8%) developed a neck hematoma which required evacuation.
Conclusion: A staged approach to combined carotid and cardiac pathology with TCAR prior to cardiac intervention appears to be a safe and effective strategy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/15385744211017704 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!